LI
INSM icon

LRI Investments’s Insmed INSM Stock Holding History

LRI Investments’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.8K Sell
307
-741
-71% -$89.7K ﹤0.01% 630
2026
Q1 		$171K Sell
1,048
-25
-2% -$3.84K 0.02% 306
2025
Q4 		$187K Buy
1,073
+3
+0.3% +$547 0.02% 293
2025
Q3 		$154K Buy
1,070
+488
+84% +$59.8K 0.01% 339
2025
Q2 		$58.6K Buy
+582
New +$44.5K 0.01% 526

Other funds holding INSM

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

LRI Investments's INSM Position: Q2 2026 in Review

LRI Investments reduced its Insmed (INSM) stake by 71% in Q2 2026, selling an estimated $89.7K and leaving 307 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #630.

LRI Investments first reported a position in INSM in Q2 2025 and has held it in 5 quarters since. The position peaked at $187K in Q4 2025. 180 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • LRI Investments held 307 shares of Insmed worth $32.8K as of Q2 2026.
  • LRI Investments sold 741 Insmed shares in Q2 2026, an estimated $89.7K.
  • Insmed made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #630 holding.
  • LRI Investments first reported a position in Insmed in Q2 2025 and has held it in 5 quarters since.
  • LRI Investments's Insmed position peaked at $187K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.